Pfizer's antifungal VFEND provides significant cost advantages when used as initial therapy

NEW YORK, June 1, 2005 Initial therapy with Pfizer's antifungal treatment, VFEND (voriconazole), IV for injection, tablets, and oral suspension, has significant cost advantages over the standard therapy, amphotericin B deoxycholate, for patients with invasive aspergillosis infections, according to a study in the June issue of Pharmacotherapy. The overall antifungal drug cost per patient was found to be $961 less for patients who began treatment with VFEND compared with patients who were started on amphotericin B. Patients treated with amphotericin B required significantly more switches to other antifungal therapy due to lack of patient response or patients' inability to tolerate the drug. This is the first published study that assesses the total antifungal drug treatment costs associated with this type of life-threatening infection.

Invasive aspergillosis is a severe pulmonary infection that can occur in patients with weakened immune systems. It often results in extended hospital stays and a significant economic burden. Economic analyses show that patients with this type of infection average 17 days in the hospital with mean treatment costs of $62,426. The overall case fatality rate for invasive aspergillosis is estimated to be 58 percent, but approaches 90-100 percent in patients where the infection has spread beyond the initial site.

"The savings observed in this analysis are directly related to the efficacy, tolerability and IV and oral dosing flexibility of VFEND. These savings are especially apparent when VFEND is used as initial therapy for these infections," said James Lewis, Pharm. D., lead investigator and infectious diseases pharmacy specialist at The University of Texas Health Science Center at San Antonio.

Study Results

Lewis and other investigators analyzed data from a previously published clinical study (Herbrecht et al. NEJM Aug 2002) which compared VFEND with standard therapy with amphotericin B deox


Page: 1 2 3 4

Related medicine news :

1. Lancet study: Pfizers Vfend equals two-drug candidemia regimen, with fewer serious side effects
2. Skin infections caused by MRSA are cured more often when treated with Pfizers ZYVOX
3. Key milestone in antifungal treatment for severe asthma
4. New analysis supports starting with VFEND for life-threatening fungal infections
5. Sports concussion research using fMRI provides insight for safe return-to-play decisions
6. Fluorescence diffuse optical tomography provides high contrast, 3-D look at breast cancer
7. Daytrana provides significant effectiveness in both boys and girls with ADHD
8. New book provides unprecedented look at role of religion over a lifetime
9. New edition of medical reference book provides the latest in hematology
10. Lung cancer screening regimen provides opportunity for cure
11. MERLIN TIMI-36 study provides new safety and efficacy data for unique anti-anginal therapy

Post Your Comments:

(Date:9/1/2020)... ... ... As fall and winter swiftly approach and many businesses cut costs to ... time to expand and grow into a full-fledged natural health clinic over the past ... relaunching its brand new website, expanding its services menu and has recruited top-tier healthcare ...
(Date:8/31/2020)... OCEAN SPRINGS, Miss. (PRWEB) , ... August 31, ... ... Pharmaceuticals Plus (GCPP) recently donated 1,400 N95 face masks to medical first responders ... company has continued to make donations of personal protective equipment (PPE) medical ...
(Date:8/31/2020)... LAWRENCEVILLE, Ga. (PRWEB) , ... August 31, 2020 , ... The pandemic and topsy-turvy economic ... to examine our budgets and look for ways to trim the fat from our monthly ... stabilize your finances, but it’s also important that you have a financial safety net in ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy ... ease than most people would. Rather than become melancholic, however, he put together a ... achieving one’s dreams. Randy Pausch took a negative situation and turned it into something ...
(Date:8/28/2020)... ... ... Integrated Viral Protection (IVP Air) today announced that the True North ... Biodefense Indoor Air Protection System that is the first system designed and proven to ... with the filtration system on September 8th. , The IVP Air S1 model ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... In response to the COVID-19 ... and classrooms across the United States, IntraLogic Solutions , a leading national ... is a non-contact, wall-mounted scanning thermometer that rapidly checks body temperatures. When a ...
(Date:9/1/2020)... ... September 01, 2020 , ... Mara C. Weinstein ... Surgery at the University of Rochester Medical Center, in Upstate New York. She ... Boston, with clinical faculty from the Harvard and Yale Departments of Dermatology and ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... today announced that they have invested $400,000 in PopBase, one of two start-ups ... with the Global Wellness Institute (GWI). , The competition was part of ...
Breaking Medicine Technology:
Cached News: